331
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The effect of a decontamination protocol on contaminated titanium dental implant surfaces with different surface topography in edentulous patients

, , , &
Pages 66-75 | Received 14 Feb 2018, Accepted 22 Jul 2018, Published online: 28 Sep 2018
 

Abstract

Objectives: To investigate if it is possible to achieve complete decontamination of dental implant surfaces with different surface characteristics.

Materials and methods: Twelve implant pieces with an Osseotite® surface and 12 implant pieces with a Ti-Unite® surface were attached on to the complete lower dentures of six patients and were allowed to accumulate plaque for 30 days. When retrieved, the implant decontamination protocol used, involved both mechanical (PeriBrush™) and chemical (3% H2O2) decontamination. The number of colony forming units per millilitre was determined and the dominant micro-organisms in selected samples was identified by 16s rRNA gene amplicon sequencing. The effect of the titanium brush on the implant surface was examined by SEM.

Results: Complete decontamination was achieved in five out of 24 implants (four Osseotite® and one Ti-Unite®). The mean CFU/ml detected after decontamination were 464.48 for Osseotite® and 729.09 for Ti-Unite® implants. On the surface of the implants in which complete decontamination was not achieved, all of the predominant bacteria identified were streptococci except for one which was identified as micrococcus. SEM images revealed that the surface features of the decontaminated implants were not significantly altered.

Conclusions: Mechanical decontamination using a titanium brush supplemented with chemical treatment for one minute (3% H2O2) can achieve complete decontamination of implant surfaces in edentulous patients.

Disclosure statement

Drs. Alotaibi, Moran, Grufferty and Polyzois declare no conflict of interest.

Dr Renvert reports grants and personal fees from Geistlich Pharma AG, Tigran Technologies and Te-Pe, personal fees from Straumann and Zimmer Biomet, and grants from OraPharma Inc. outside the submitted work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.